Compare StocksJNJ vs PODD

Johnson & Johnson (JNJ) vs Insulet Corporation (PODD): Which Is the Better Buy in 2026?

As of 2026-09-17, JNJ is fairly valued at $269, with a DCF intrinsic value of $303 and a margin of safety of 11%. PODD is fairly valued at $140, with an intrinsic value of $137 and a margin of safety of -2%. Of the two, JNJ has the wider margin of safety.

JNJ
Johnson & Johnson
$268.69
VS
PODD
Insulet Corporation
$139.74

Rewards

JNJ
  • Johnson & Johnson has maintained ROIC above 15% for 4 consecutive years, indicating a durable competitive advantage.
  • Gross margin of 68.1% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • Johnson & Johnson scores 90/100 on the Economic Moat Score (Wide Moat), with revenue predictability as the strongest competitive dimension.
PODD
  • Gross margin of 71.1% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • Each dollar of retained earnings has created $3.09 of earning power — management is an exceptional capital allocator.
  • Trailing P/E of 26.2x is 98% below the historical average of 1100.9x — potentially undervalued relative to its own history.

Risks

JNJ
  • FCF yield of 2.6% is below 3%, meaning the market is pricing in substantial future growth to justify the current price.
  • Trailing P/E of 31.1x is 56% above the historical average of 20.0x — the stock trades at a premium to its own history.
  • PEG ratio of 2.79 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
PODD

    Key Valuation Metrics

    Learn more →
    JNJ
    PODD
    Valuation
    $16.89B
    Free Cash Flow
    $349.90M
    2.61%
    FCF Yield
    3.61%
    31.13
    Trailing P/E
    26.22
    21.87
    Forward P/E
    18.12
    Quality & Moat
    16.85%
    ROIC
    16.46%
    25.74%
    ROE
    26.02%
    68.14%
    Gross Margin
    71.08%
    2.79
    PEG Ratio
    1.11
    Balance Sheet Safety
    0.33
    Net Debt / Equity
    0.29
    N/A
    Interest Coverage
    N/A
    0.81
    Net Debt / EBITDA
    0.67
    2.01%
    Dividend Yield
    0.00%
    JNJ: 2Ties: 4PODD: 6
    JNJPODD

    Historical Fundamentals

    Learn more →
    JNJ

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    PODD

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    $1 Retained Earnings Test

    Learn more →
    JNJ
    $0.91
    created per $1 retained over 3 years
    Mediocre Allocator
    Σ Retained
    $40.05B
    Δ Market Cap
    +$36.63B
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
    PODD
    $-0.52
    created per $1 retained over 3 years
    Market Cap Declined
    Σ Retained
    $871.7M
    Δ Market Cap
    $-455.5M
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Discounted Cash Flow (DCF) Analysis

    Learn more →
    JNJ
    11.2% Margin of Safety
    Price is 11.2% below estimated fair value
    Current Price: $268.69
    Fair Value: $302.57
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued
    PODD
    1.8% Overvalued
    Price is 1.8% above estimated fair value
    Current Price: $139.74
    Fair Value: $137.29
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued

    Reverse DCF — Market-Implied Growth

    Learn more →
    JNJ

    What growth rate is the market pricing in at $269?

    +9.8%
    Market-Implied Owner Earnings Growth
    Standard FCF implies +17.1%

    The market implies +9.8% Owner Earnings growth, above historical trends.

    Standard FCF implies a demanding +17.1%, reflecting heavy growth investment.

    PODD

    What growth rate is the market pricing in at $140?

    +17.4%
    Market-Implied Owner Earnings Growth
    Standard FCF implies +12.7%

    The market implies +17.4% Owner Earnings growth, below historical trends — potential opportunity.

    Standard FCF implies a more demanding +12.7%, reflecting heavy growth investment expected to generate future returns.

    Economic Moat Score

    Learn more →
    JNJ
    90/100
    Wide Moat
    70+ Wide · 40-69 Narrow · <40 None

    Wide moat with strength across all dimensions. Revenue Predictability is the standout factor.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.
    PODD
    55/100
    Narrow Moat
    70+ Wide · 40-69 Narrow · <40 None

    Narrow moat with revenue predictability as the key competitive advantage. Improving roic consistency would strengthen the moat.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

    Forensic Accounting

    Learn more →
    JNJ
    -2.31
    Unlikely Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
    PODD
    -2.51
    Unlikely Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Ownership Breakdown

    Learn more →
    JNJ
    Insiders 0.1%Institutions 76.7%Retail & Other 23.2%
    No. of Institutional Holders5,826
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
    PODD
    Insiders 0.3%Institutions 107.1%
    No. of Institutional Holders1,099
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

    High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

    Insider Buying Activity

    Learn more →
    JNJ
    0
    Buys (3M)
    1
    Buys (12M)
    Total value (12M): $257,688
    MORIKIS JOHN G
    Director
    $257,688
    @ $206.15 · 2025-11-26
    WEINBERGER MARK A
    Director
    $147,220
    @ $147.22 · 2024-12-12
    Open market purchases · includes direct & indirect ownership · excludes option exercises
    PODD
    0
    Buys (3M)
    4
    Buys (12M)
    Total value (12M): $1.70M
    WEATHERMAN ELIZABETH H
    Director
    $497,490
    @ $144.20 · 2026-06-03
    STONESIFER TIMOTHY C
    Director
    $400,393
    @ $143.51 · 2026-06-03
    MINOGUE MICHAEL R
    Director
    $499,847
    @ $246.23 · 2026-02-25
    STONESIFER TIMOTHY C
    Director
    $299,884
    @ $311.73 · 2025-12-05
    Open market purchases · includes direct & indirect ownership · excludes option exercises

    Open market purchases · includes direct & indirect ownership · excludes option exercises.

    Insider Selling Activity

    Learn more →
    JNJ
    6
    Sells (3M)
    15
    Sells (12M)
    Total value (12M): $132.73M
    SCHMID TIMOTHY
    Officer
    $9.23M
    @ $274.74 · 2026-09-02
    TAUBERT JENNIFER L
    Officer
    $3.95M
    @ $263.36 · 2026-08-17
    DUATO JOAQUIN BOIX
    Chief Executive Officer
    $32.20M
    @ $261.17 · 2026-08-13
    FORMINARD ELIZABETH
    Officer
    $4.09M
    @ $257.00 · 2026-08-06
    DUATO JOAQUIN BOIX
    Chief Executive Officer
    $12.52M
    @ $258.15 · 2026-08-05
    BROADHURST VANESSA
    Officer
    $5.79M
    @ $251.27 · 2026-07-20
    WENGEL KATHRYN E
    Chief Technology Officer
    $2.41M
    @ $241.15 · 2026-06-11
    DECKER ROBERT J
    Officer
    $1.01M
    @ $247.87 · 2026-02-27
    SCHMID TIMOTHY
    Officer
    $324,763
    @ $245.66 · 2026-02-20
    SCHMID TIMOTHY
    Officer
    $5.53M
    @ $244.33 · 2026-02-18
    REED JOHN C
    Officer
    $13.11M
    @ $243.00 · 2026-02-17
    WOLK JOSEPH J
    Chief Financial Officer
    $21.77M
    @ $242.80 · 2026-02-17
    SWANSON JAMES D
    Chief Technology Officer
    $15.11M
    @ $243.39 · 2026-02-17
    BROADHURST VANESSA
    Officer
    $1.51M
    @ $243.39 · 2026-02-17
    REED JOHN C
    Officer
    $4.19M
    @ $192.71 · 2025-10-17
    TAUBERT JENNIFER L
    Officer
    $10.04M
    @ $177.81 · 2025-09-04
    DUATO JOAQUIN BOIX
    Chief Executive Officer
    $22.55M
    @ $179.21 · 2025-08-22
    WOLK JOSEPH J
    Chief Financial Officer
    $2.98M
    @ $176.91 · 2025-08-15
    REED JOHN C
    Officer
    $3.13M
    @ $163.55 · 2025-07-17
    DECKER ROBERT J
    Officer
    $1.16M
    @ $165.88 · 2025-02-25
    SCHMID TIMOTHY
    Officer
    $62,928
    @ $156.15 · 2025-02-18
    WOLK JOSEPH J
    Chief Financial Officer
    $2.00M
    @ $153.89 · 2025-02-07
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
    PODD
    0
    Sells (3M)
    2
    Sells (12M)
    Total value (12M): $602,397
    BORIO LUCIANA
    Director
    $59,887
    @ $143.27 · 2026-06-03
    FREDERICK WAYNE A.I.
    Director
    $542,510
    @ $293.09 · 2025-12-15
    SINGH PREM
    Officer
    $238,726
    @ $347.49 · 2025-09-08
    COUSIN LAETITIA
    Officer
    $278,002
    @ $348.81 · 2025-09-08
    BENJAMIN ERIC
    Officer
    $1.42M
    @ $332.23 · 2025-08-21
    SINGH PREM
    Officer
    $429,760
    @ $320.00 · 2025-08-07
    SINGH PREM
    Officer
    $698,216
    @ $300.05 · 2025-06-13
    MANEA DANIEL
    Officer
    $390,065
    @ $300.05 · 2025-06-13
    BORIO LUCIANA
    Director
    $147,056
    @ $305.73 · 2025-06-09
    KAPPLES JOHN W.
    General Counsel
    $1.68M
    @ $318.47 · 2025-05-14
    HOPFIELD JESSICA
    Director
    $1.66M
    @ $317.54 · 2025-05-13
    BENJAMIN ERIC
    Officer
    $960,320
    @ $320.00 · 2025-05-13
    FREDERICK WAYNE A.I.
    Director
    $501,875
    @ $275.00 · 2025-03-25
    BENJAMIN ERIC
    Officer
    $3.47M
    @ $280.00 · 2025-01-21
    BENJAMIN ERIC
    Officer
    $1.17M
    @ $267.60 · 2024-12-16
    BUDDEN LAUREN
    Officer
    $252,192
    @ $275.62 · 2024-12-10
    BORIO LUCIANA
    Director
    $139,598
    @ $274.80 · 2024-11-12
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

    🎭 Mr. Market's Mood

    Learn more →
    JNJ
    FearGreed
    😏Greed(68/100)

    "Market is optimistic — be cautious and ensure you have a margin of safety"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
    PODD
    FearGreed
    😨Fear(31/100)

    "Market is pessimistic — investigate whether fears are temporary or structural"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    ⚖️ Buffett Signal

    Learn more →
    JNJ
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Greed (68)
    PODD
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Fear (31)
    View JNJ Full AnalysisView PODD Full Analysis

    Frequently Asked Questions: JNJ vs PODD

    Is Johnson & Johnson or Insulet Corporation more undervalued in 2026?

    Based on our discounted cash flow model, JNJ trades at a 11.2% margin of safety (intrinsic value $303 vs. price $269), compared to PODD's -1.8% margin of safety (intrinsic $137 vs. $140).

    Which stock has a wider economic moat, Johnson & Johnson or Insulet Corporation?

    JNJ scores 90/100 (Wide moat), while PODD scores 55/100 (Narrow moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

    Which company has better free cash flow, Johnson & Johnson or Insulet Corporation?

    Insulet Corporation (PODD) generates a 3.6% free cash flow yield, compared to Johnson & Johnson's 2.6%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

    Which stock has higher return on invested capital, Johnson & Johnson or Insulet Corporation?

    JNJ earns 16.9% ROIC versus PODD's 16.5%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.